U.S. Physical Therapy, Inc. (NYSE:USPH) – Cantor Fitzgerald issued their FY2019 earnings estimates for shares of U.S. Physical Therapy in a research note issued on Tuesday, May 22nd, Zacks Investment Research reports. Cantor Fitzgerald analyst J. France anticipates that the company will post earnings of $2.65 per share for the year. Cantor Fitzgerald currently has a “Neutral” rating on the stock.
Other equities analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $89.00 target price for the company in a research note on Wednesday, March 7th. ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, March 9th. Jefferies Financial Group set a $76.00 price target on shares of U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, February 23rd. Finally, Sidoti cut shares of U.S. Physical Therapy from a “buy” rating to a “neutral” rating in a report on Wednesday, April 25th. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. U.S. Physical Therapy currently has a consensus rating of “Hold” and a consensus target price of $79.40.
Shares of NYSE USPH traded up $1.10 on Wednesday, reaching $96.90. 67,800 shares of the company’s stock traded hands, compared to its average volume of 53,204. U.S. Physical Therapy has a 12 month low of $56.50 and a 12 month high of $97.90. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of 46.75, a P/E/G ratio of 3.46 and a beta of 1.05. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.67 and a current ratio of 1.67.
U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, May 3rd. The company reported $0.56 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.56. U.S. Physical Therapy had a net margin of 4.90% and a return on equity of 13.20%. The business had revenue of $108.34 million during the quarter, compared to the consensus estimate of $107.18 million.
The company also recently declared a quarterly dividend, which was paid on Friday, June 8th. Stockholders of record on Friday, May 11th were issued a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend was Thursday, May 10th. U.S. Physical Therapy’s payout ratio is 44.23%.
In related news, Director Mark J. Brookner sold 1,250 shares of the firm’s stock in a transaction that occurred on Wednesday, May 16th. The shares were sold at an average price of $91.83, for a total value of $114,787.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Edward L. Kuntz sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 11th. The stock was sold at an average price of $92.02, for a total transaction of $184,040.00. Following the completion of the sale, the director now owns 3,750 shares in the company, valued at approximately $345,075. The disclosure for this sale can be found here. In the last quarter, insiders have sold 19,561 shares of company stock worth $1,800,003. Corporate insiders own 2.50% of the company’s stock.
A number of hedge funds have recently modified their holdings of the stock. Citigroup Inc. boosted its holdings in U.S. Physical Therapy by 5.9% in the first quarter. Citigroup Inc. now owns 10,731 shares of the company’s stock worth $873,000 after purchasing an additional 597 shares during the last quarter. Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 0.4% in the first quarter. Copeland Capital Management LLC now owns 173,261 shares of the company’s stock worth $14,086,000 after acquiring an additional 693 shares during the period. Bahl & Gaynor Inc. raised its position in U.S. Physical Therapy by 3.5% in the first quarter. Bahl & Gaynor Inc. now owns 28,285 shares of the company’s stock worth $2,300,000 after acquiring an additional 950 shares during the period. Kings Point Capital Management raised its position in U.S. Physical Therapy by 3.7% in the fourth quarter. Kings Point Capital Management now owns 28,096 shares of the company’s stock worth $2,029,000 after acquiring an additional 1,000 shares during the period. Finally, Swiss National Bank raised its position in U.S. Physical Therapy by 5.3% in the first quarter. Swiss National Bank now owns 21,900 shares of the company’s stock worth $1,780,000 after acquiring an additional 1,100 shares during the period. Institutional investors own 96.66% of the company’s stock.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.